The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Share News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: C4X Shares Double On Indivior Licensing Deal

Thu, 29th Mar 2018 10:28

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Wm Morrison Supermarkets, up 2.7%. Bernstein raised the grocer to Outperform from Market Perform.Mediclinic International, up 1.8%. The private healthcare operator said chief executive designate, Ronnie van der Merwe, will begin his new role as CEO in June, whilst it also announced the departure of two non-executive directors, Nandi Mandela and Robert Leu.----------FTSE 100 - LOSERS----------Compass, down 3.1%. The caterer was lower after a weak set of half-year results from French peer Sodexo. Organic revenue growth of 1.7% for the first half of its financial year and and underlying operating margin of 6.1% were both below expectations, the company said. Sodexo said it expects revenue decline in North America and a slower than anticipated conversion of pipeline opportunities into new contract wins will weigh on top line growth and margins in the second half. "Investors clearly worry that Sodexo's pain is representative of the catering market as a whole, therefore Compass is at risk," said AJ Bell investment director Russ Mould.Shire, down 2.0%. The drugmaker was giving up some of Wednesday's gains, when it closed up 14% on news Japanese pharmaceutical firm Takeda Pharmaceutical confirmed it is "considering making an approach" for London-listed firm.----------FTSE 250 - WINNERS----------IP Group, up 8.6%. The intellectual property swung to a GBP53.4 million pretax profit for 2017 from a GBP14.8 million loss the year prior. IP Group reported an increase in the fair value of its portfolio to GBP1.1 billion from GBP614.0 million in 2016. It had assets of GBP1.5 billion as at the end of December, up from GBP768.7 million assets it had the year before. "Overall, the underlying performance of the group's enlarged portfolio was strong with a number of key milestones attained. The integration of Touchstone Innovations with IP Group is proceeding to plan and we are confident for the year ahead and beyond," IP Chief Executive Officer Alan Aubrey said.----------FTSE 250 - LOSERS----------Provident Financial, down 2.0%. The subprime lender was cut to Sell from Hold by Berenberg.----------OTHER MAIN MARKET AND AIM - WINNERS----------C4X Discovery, shares more than doubling to 115.00p from Wednesday's close of 56.50p. FTSE 250-listed Indivior said its subsidiary Indivior UK and C4X Discovery have entered into a license agreement, whereby Indivior UK has obtained "exclusive global rights" to develop and commercialize C4X's oral orexin-1 receptor antagonist program. Under the terms of the agreement, Indivior UK will make an upfront payment to C4X of USD10 million with potential milestone payments to C4X that could total USD284 million "over time", if all development, regulatory and commercial goals are achieved. Indivior was down 0.1%.CMC Markets, up 8.6%. The online trading platform said its "strong" performance in the year to date was maintained in its final quarter ending Saturday as its Australian partnership continues to progress. CMC expects net operating income to be "significantly" higher than the prior year after a strong second half performance. In financial 2017, CMC reported net operating income of GBP160.8 million alongside a pretax profit of GBP48.5 million. "The proportion of high value clients has increased," CMC said in a statement, "driving a significant improvement in revenue per client compared to the prior year. Overall, active client numbers are slightly below the previous year although the final quarter has seen an increase from the prior year."----------OTHER MAIN MARKET AND AIM - LOSERS----------South African Property Opportunities, down 90%. The company said it intends to propose the winding-up of the company shortly after the unsuccessful attempt to sell its Brakpan asset. The firm said it had contracted to sell the Brakpan asset - as part of its strategy to sell its remaining assets - for ZAR11 million, or GBP650,000. However, the company attempted to enforce this contract without success. As South African Property now considers that it is "no longer practicable" to operate in the hope of generating meaningful proceeds from a disposal of the Brakpan Asset, the board will shortly place proposals before shareholders for a voluntary winding-up, the appointment of a liquidator and the cancellation of its shares on AIM.----------
More News
7 May 2020 17:57

C4X Discovery Raises GBP1.6 Million Via Share Placing

C4X Discovery Raises GBP1.6 Million Via Share Placing

Read more
24 Jan 2020 15:59

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jan 2020 10:40

C4X Discovery Annual Loss Widens, Confident In Strategy

C4X Discovery Annual Loss Widens, Confident In Strategy

Read more
7 Jan 2020 09:59

C4X losses widen as its revenue drops to nil

(Sharecast News) - Drug discovery company C4X Discovery Holdings announced a fall in revenue to nil in its full-year results on Tuesday, from £7.06m in 2018, which the board said as driven entirely by the Indivior licensing agreement in that year.

Read more
31 Dec 2019 10:47

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
24 Oct 2019 17:06

UPDATE: C4X Discovery Raises GBP7 Million In Discounted Placing

UPDATE: C4X Discovery Raises GBP7 Million In Discounted Placing

Read more
24 Oct 2019 11:09

C4X Discovery Raises Over GBP5 Million In Discounted Placing

C4X Discovery Raises Over GBP5 Million In Discounted Placing

Read more
24 Oct 2019 10:31

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

Read more
1 Oct 2019 10:15

C4X makes solid progress across portfolio of programmes

(Sharecast News) - Drug discovery company C4X Discovery Holdings announced progress across a number of key programmes in line with its strategy on Tuesday, reporting that it was continuing to progress its strategy to deliver programmes for out-licensing its NRF-2 activator, IL-17 inhibitor and LifeArc collaboration.

Read more
27 Sep 2019 15:39

C4X upbeat as its molecule progresses with Indivior

(Sharecast News) - Drug discovery company C4X Discovery Holdings noted an announcement on Friday that the National Institutes of Health (NIH) in the United States has granted Indivior's application titled "Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor Antagonist for the Treatment of Opioid Use Disorder'.

Read more
2 Sep 2019 12:02

Former Glaxo Vice President To Lead C4X Discovery Advisory Network

(Alliance News) - C4X Discovery Holdings PLC on Monday said it is forming a drug discovery advisory network chaired by "renowned industry veteran" Robin Carr.Shares in C4X were up

Read more
30 Apr 2019 12:59

C4X Discovery Interim Loss Widens, Focuses On Inking Deals

LONDON (Alliance News) - C4X Discovery Holdings PLC said on Tuesday it had a "strong" first half, though its loss widened on higher research and development costs.The drug firm to

Read more
23 Apr 2019 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 24 AprilĀ PetropavolskFull Year ResultsBoohoo GroupFull Year HealthFull

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.